Eli Lilly nears $2 bln deal for cancer biotech Kelonia, WSJ reports

Business
Advertisements



Eli Lilly nears $2 bln deal for cancer biotech Kelonia, WSJ reports


Advertisements

Leave a Reply

Your email address will not be published. Required fields are marked *